A comprehensive method for predicting fatal liver failure of patients with liver cancer resection.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4603037)

Published in Medicine (Baltimore) on May 01, 2015

Authors

Jiangfa Li1, Biao Lei, Xingju Nie, Linku Lin, Syed Abdul Tahir, Wuxiang Shi, Junfei Jin, Songqing He

Author Affiliations

1: From the Department of Hepatobiliary and Pancreatic Surgery (JL, LL, SAT, SH); Laboratory of Hepatobiliary and Pancreatic Surgery (JL, BL, JJ, SH), Affiliated Hospital of Guilin Medical University; Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair (JJ, SH); School of Public Health (WS), Guilin Medical University, Guilin, Guangxi, People's Republic of China; and Department of Radiology and Radiological Science (XN), Center for Biomedical Imaging, Medical University of South Carolina, Charleston, South Carolina, USA.

Articles cited by this

Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26

A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition (1992) 16.89

The global health burden of infection-associated cancers in the year 2002. Int J Cancer (2006) 13.57

Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology (2010) 5.44

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol (2007) 4.59

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology (2011) 3.46

Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg (2011) 3.10

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol (2007) 2.37

Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05

Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg (2010) 1.85

Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg (2009) 1.73

Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42

Vascular control during hepatectomy: review of methods and results. World J Surg (2005) 1.36

Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg (1994) 1.32

Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg (2011) 1.29

Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg (2009) 1.27

Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis. Am J Gastroenterol (2007) 1.04

High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer (2009) 0.99

Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg (2010) 0.98

Risk factors for major morbidity after liver resection for hepatocellular carcinoma. Br J Surg (2012) 0.94

Portal triad clamping versus vascular exclusion for vascular control during hepatic resection: a systematic review and meta-analysis. J Gastrointest Surg (2008) 0.92

Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy. PLoS One (2014) 0.92

Safety of hepatic resection in overweight and obese patients with cirrhosis. Br J Surg (2011) 0.90

Association between central venous pressure and blood loss during hepatic resection in 984 living donors. Acta Anaesthesiol Scand (2009) 0.89

Significance of the effective remnant liver volume in major hepatectomies. Am Surg (2005) 0.89

Predictors of peri-opertative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease. HPB (Oxford) (2011) 0.88

Diabetes worsens the surgical outcomes in cirrhotic patients with hepatocellular carcinoma. Tohoku J Exp Med (2012) 0.88

Potential factors dedicated to postoperative liver dysfunction in patients with normal preoperative ICG-15 clearance rate. Dig Dis Sci (2012) 0.86

Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis. Surg Today (2013) 0.85

Decreased blood loss reduces postoperative complications in resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci (2014) 0.83

A new scoring system for assessment of liver function after successful hepatectomy in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2011) 0.82

Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation. Clin Transplant (2011) 0.82

Indocyanine green retention test avoiding liver failure after hepatectomy for hepatolithiasis. Hepatogastroenterology (2012) 0.81

Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution. Int J Clin Oncol (2013) 0.81

Study of perioperative liver function by dynamic monitoring of ICG-clearance. Hepatogastroenterology (2012) 0.81

The Interaction between Diabetes, Body Mass Index, Hepatic Steatosis, and Risk of Liver Resection: Insulin Dependent Diabetes Is the Greatest Risk for Major Complications. HPB Surg (2014) 0.77

Articles by these authors

Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells (2007) 1.54

Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res (2007) 1.50

Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P. FASEB J (2006) 1.30

Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes. J Invest Dermatol (2007) 1.23

Golgi fragmentation is associated with ceramide-induced cellular effects. Mol Biol Cell (2005) 1.21

Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload. J Card Fail (2008) 1.13

Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J Card Fail (2008) 1.06

Substrate specificity, membrane topology, and activity regulation of human alkaline ceramidase 2 (ACER2). J Biol Chem (2010) 1.03

Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload. Am J Physiol Heart Circ Physiol (2007) 1.03

TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. J Endocrinol (2013) 1.02

Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure. Am J Physiol Heart Circ Physiol (2008) 1.01

Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress. J Biol Chem (2011) 1.00

Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion. FASEB J (2008) 1.00

High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets. J Hypertens (2008) 0.99

Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination. NMR Biomed (2014) 0.97

Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol Cancer Ther (2010) 0.95

Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler Thromb Vasc Biol (2012) 0.93

Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation. J Immunol (2010) 0.92

ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin. Lipids Health Dis (2010) 0.91

Ethanol induces apoptosis in hepatocytes by a pathway involving novel protein kinase C isoforms. Cell Signal (2007) 0.91

Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells. PLoS One (2013) 0.89

Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes. FASEB J (2010) 0.89

Mitochondrially targeted ceramides preferentially promote autophagy, retard cell growth, and induce apoptosis. J Lipid Res (2010) 0.88

Low-dose cytokine-induced neutral ceramidase secretion from INS-1 cells via exosomes and its anti-apoptotic effect. FEBS J (2014) 0.82

Inhibition of AMP-activated protein kinase pathway sensitizes human leukemia K562 cells to nontoxic concentration of doxorubicin. Mol Cell Biochem (2010) 0.81

The role of acid sphingomyelinase and caspase 5 in hypoxia-induced HuR cleavage and subsequent apoptosis in hepatocytes. Biochim Biophys Acta (2012) 0.81

Acute activation of acid ceramidase affects cytokine-induced cytotoxicity in rat islet beta-cells. FEBS Lett (2009) 0.81

Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo. Int J Oncol (2013) 0.80

EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3. Med Oncol (2014) 0.78

Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs. Am J Physiol Heart Circ Physiol (2006) 0.78

TLR4 activation and IL-6-mediated cross talk between adipocytes and mononuclear cells synergistically stimulate MMP-1 expression. Endocrinology (2011) 0.77

Clinicopathological significance of CXCR4 expression in renal cell carcinoma: a meta-analysis. Ann Surg Oncol (2014) 0.77

Relationship between female hormonal and menstrual factors and pancreatic cancer: a meta-analysis of observational studies. Medicine (Baltimore) (2015) 0.76

MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-γ and high glucose in mononuclear cells - a potential role of MD-2 in Toll-like receptor 4-independent signalling. Immunology (2013) 0.76

Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease. Transplantation (2015) 0.76

Targeted complement inhibition protects vascularized composite allografts from acute graft injury and prolongs graft survival when combined with subtherapeutic cyclosporine A therapy. Transplantation (2016) 0.75

Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma. Medicine (Baltimore) (2016) 0.75

Surgical treatment of hepatocellular carcinoma with cirrhotic esophageal varices and hypersplenism: a 184 case report. Front Med China (2007) 0.75

[The model's establishment of the single cell (HepG2) clones over expressed ARL-1 gene]. Zhonghua Gan Zang Bing Za Zhi (2002) 0.75

Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs. J Appl Physiol (1985) (2003) 0.75

Hepatic angiomyolipoma demonstrating similar imaging characteristics as hepatocellular carcinoma: one case report. J Huazhong Univ Sci Technolog Med Sci (2005) 0.75